Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.6 |
mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.7 |
mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |